Hidetoshi Sakurai

Papers

Total Citations

H-Index

About

Dr. Hidetoshi Sakurai is a pioneering stem cell biologist whose work centers on induced pluripotent stem cell (iPSC) technology and its application in drug discovery. His major contribution lies in overcoming a critical bottleneck in the field: the labor-intensive, highly skilled nature of iPSC maintenance and differentiation. By establishing a robust platform that integrates the Maholo LabDroid—a fully automated robotic system—Sakurai has demonstrated that complex stem cell cultures can be standardized and scaled with precision, reducing human error and technical variability. His landmark 2021 paper (22 citations) showcases how this platform enables reliable, high-throughput iPSC research, accelerating early drug discovery pipelines. Beyond this, Sakurai’s broader work has advanced our understanding of disease modeling using patient-derived iPSCs, particularly for neuromuscular disorders. His achievements include developing protocols that make stem cell research more accessible to laboratories without specialized expertise, democratizing the field. With a growing citation impact, Sakurai’s innovations are shaping the future of regenerative medicine and pharmaceutical development, offering a scalable solution to one of stem cell biology’s most persistent challenges.